½ÃÀ庸°í¼­
»óǰÄÚµå
1787969

¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø : Á¦Ç°º°, »óó À¯Çüº°, ¿ë¾×º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(-2032³â)

Wound Irrigation Systems Market Forecasts to 2032 - Global Analysis By Product (Manual Wound Irrigation Systems, Battery-Operated Wound Irrigation Systems, Gravity Feed Systems and Pressure-Based Systems), Wound Type, Solution, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é »óó ¼¼Ã´ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 3¾ï 1,990¸¸ ´Þ·¯, 2032³â¿¡´Â 4¾ï 6,530¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 5.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

»óó ¼¼Ã´ ½Ã½ºÅÛÀº ÀϹÝÀûÀ¸·Î »ý¸® ½Ä¿°¼ö ¹× ¼Òµ¶Á¦¿Í °°Àº ¿ë¾×À» Á¦¾îµÈ À¯¼ÓÀ¸·Î °ø±ÞÇÏ¿© »óó¸¦ ¼¼Ã´Çϰí ÀÜ·ù¹°, ¹ÚÅ׸®¾Æ ¹× »ïÃâ¹°À» Á¦°ÅÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±â ¶Ç´Â ¹æ¹ýÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº °¨¿°À» ¿¹¹æÇϰí Ä¡À¯¸¦ °¡¼ÓÈ­ÇÏ°í ½ÀÇÑ »óó ȯ°æÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼ö¼úâ, ¿Ü»ó, ¸¸¼º±Ë¾ç, ¿­»ó µî¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. »óó ¼¼Ã´Àº ¼öµ¿ ÁÖ»ç±â, Áß·Â ½Ã½ºÅÛ ¶Ç´Â µ¿·Â ¼¼Ã´ ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀûÀýÇÑ ¼¼Ã´Àº ¹ÙÀÌ¿ÀÇʸ§ÀÇ Çü¼ºÀ» ¾ïÁ¦Çϰí, Á¶Á÷ÀÇ Àç»ýÀ» ÃËÁøÇϰí, »óóÃþÀÇ µå·¹½Ì ¹× »óó Æó¼â¸¦ ÁغñÇÕ´Ï´Ù.

Health Research Educational Trust(HRET)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ ¾à 1,500¸¸°ÇÀÇ ¼ö¼úÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ȯÀÚÀÇ ¾à 2.0%-5.0%°¡ ¼ö¼ú ºÎÀ§ °¨¿°À» °æÇèÇϰí ÀÖ½À´Ï´Ù.

±ÞÁõÇÏ´Â ¸¸¼º »óó¿Í ¼ö¼ú ÈÄ Ä¡·á ÇÊ¿ä

´ç´¢º´¼º ¹ß±Ë¾ç, ¿åâ, Á¤¸Æ¼º Çã¹÷Áö ±Ë¾ç µîÀÇ ¸¸¼º »óóÀÇ À¯º´·ü »ó½Â°ú ¼ö¼ú ÈÄ Äɾî´ÏÁî Áõ°¡°¡ »óó ¼¼Ã´ ½Ã½ºÅÛ ¼ö¿ä¸¦ Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »óÅ¿¡¼­´Â °¨¿°À» ¹æÁöÇϰí Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇØ ÀϰüµÇ°í È¿°úÀûÀÎ »óó ¼¼Ã´ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¼¼°èÀûÀ¸·Î ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÏ°í ¸¸¼º ÁúȯÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó ÀÇ·á Á¾»çÀÚµéÀº ¸ê±Õ »óó ȯ°æÀ» È®º¸Çϱâ À§ÇØ °í±Þ ¼¼Á¤ ½Ã½ºÅÛÀ» äÅÃÇÏ´Â °ÍÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í »óó ÄÉ¾î ±â¼úÀÇ Çõ½Å ±âȸ¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.

°í±Þ ¼¼Ã´ ½Ã½ºÅÛÀÇ ³ôÀº °¡°Ý

÷´Ü »óó ¼¼Ã´ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ëÀº ƯÈ÷ ºñ¿ë¿¡ ¹Î°¨Çϰí ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ½ÃÀå ¼ºÀåÀÇ Å« À庮À̵Ǿú½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº È¿°úÀûÀÌÁö¸¸ Àåºñ¿Í À¯Áö º¸¼ö¿¡ ¸¹Àº ÅõÀÚ°¡ ÇÊ¿äÇÏ¸ç ¼Ò±Ô¸ð ÀÇ·á½Ã¼³°ú ³óÃÌ Áö¿ªÀÇ µµÀÔÀÌ Á¦Çѵ˴ϴÙ. ÀÌ·¯ÇÑ °æÁ¦Àû ºÎ´ãÀº ƯÈ÷ ÀÇ·á ¿¹»êÀÇ Á¦¾àÀ¸·Î °í¹ÎÇÏ´Â ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ º¸±ÞÀ» ÀúÇØÇϰí ȯÀÚÀÇ Áøº¸µÈ ÀÇ·á¿¡ ´ëÇÑ Á¢±ÙÀ» Á¦ÇÑÇÏ¸ç ½ÃÀå ÀüüÀÇ Ä§Åõ¸¦ Áö¿¬½Ãŵ´Ï´Ù.

±â¼ú Çõ½Å°ú Á¦Ç° ÁøÈ­

±â¼ú Çõ½Å°ú Áö¼ÓÀûÀÎ Á¦Ç° ÁøÈ­°¡ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ ¾Ð·Â Á¦¾î, ÈÞ´ë¿ë ¼³°è ¹× Ç×±Õ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ» Ư¡À¸·Î Çϴ ÷´Ü ½Ã½ºÅÛÀº »óó °ü¸®ÀÇ Á¤È®¼º, ¾ÈÀü¼º ¹× »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº °¨¿° À§ÇèÀ» ÁÙÀ̰í Ä¡À¯¸¦ ÃËÁøÇϰí ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۱â À§ÇØ ¼ö¼ú°ú ¸¸¼º âÀ» ¸ðµÎ °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á½Ã¼³¿¡¼­ ½º¸¶Æ®Çϰí È¿À²ÀûÀÎ ¼¼Ã´ µµ±¸¸¦ äÅÃÇÔ¿¡ µû¶ó ±â¼úÀûÀ¸·Î ÷´Ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÏ°í ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀåÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

³óÃ̰ú °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ º¸±ÞÀº Á¦ÇÑÀûÀÔ´Ï´Ù.

³óÃ̰ú ½ÅÈï±¹ ½ÃÀå¿¡ ´ëÇÑ º¸±ÞÀÌ Á¦ÇÑµÇ¾î »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ÃæºÐÇÏÁö ¾ÊÀ¸¸ç ¼±Áø ÀÇ·á±â±â¿¡ ´ëÇÑ ¾×¼¼½º°¡ Á¦ÇѵǾî ÀÖÀ¸¸ç ÈÆ·Ã¹ÞÀº Àü¹®°¡°¡ ºÎÁ·ÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. °á°úÀûÀ¸·Î »óó ¼¼Ã´ ½Ã½ºÅÛÀÇ µµÀÔÀº ÃÖ¼ÒÇÑÀ¸·Î À¯ÁöµÇ°í ½ÃÀå È®´ë¸¦ ¾ïÁ¦ÇÕ´Ï´Ù. °æÁ¦Àû Á¦¾à°ú ÀÎ½Ä ºÎÁ·ÀÌ ¹®Á¦¸¦ ´õ¿í ½É°¢ÇÏ°Ô Çϰí, ÃæºÐÇÑ ¼­ºñ½º¸¦ ¹ÞÁö ¸øÇÑ »ç¶÷µé ¼ö¿ä¿Í Á¢±Ù »çÀÌ¿¡ Å« °ÝÂ÷°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ À¯ÇàÀº Ãʱ⿡ ¼±Åà ¼ö¼úÀÇ ¿¬±â¿Í º´¿ø ¼ö¿ë ´É·ÂÀÇ °¨¼Ò·Î »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀåÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ±×·¯³ª ÀÇ·á ½Ã½ºÅÛÀÌ ÀûÀÀÇÔ¿¡ µû¶ó Áß¿äÇÑ Äɾî ȯ°æ¿¡¼­ °¨¿° ÅëÁ¦¿Í »óó ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. À§»ý°ü¸®, ¿ø³» °¨¿° ¿¹¹æ, COVID ÈÄ ÇÕº´Áõ ¿¹¹æ¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡°¡ ¼ºÀåÀ» ȸº¹½ÃÄ×½À´Ï´Ù. ÀÌ À§±â´Â È¿À²ÀûÀÎ »óó °ü¸®ÀÇ Á߿伺À» ºÎ°¢½ÃŰ°í »õ·Î¿î ÅõÀÚ¿Í °í±Þ °ü°³ ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ±Þ¼º »óó ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

»ç°í, ¼ö¼ú, ¿Ü»óÀ¸·Î ÀÎÇÑ ºÎ»ó ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ±Þ¼º »óó ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á Á¦°ø¾÷ü´Â °¨¿°À» ¿¹¹æÇÏ°í ´õ ºü¸¥ Ä¡À¯¸¦ Áö¿øÇϱâ À§ÇØ »óóÀÇ Áï°¢ÀûÀÎ ¼¼Ã´À» Áß½ÃÇϰí ÀÖÀ¸¸ç, °í±Þ ¼¼Ã´ ½Ã½ºÅÛ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Àúħ½À ¼ö¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í »óó À§»ý¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀåÀ» ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â ÀÓ»óÀûÀ¸·Î ±ä±Þ¼ºÀÌ ³ô±â ¶§¹®¿¡ ±¸±ÞÀ̳ª ¼ö¼úÀÇ ÇöÀå¿¡¼­ ²ÙÁØÇÑ ±â¼ú Çõ½ÅÀÌ ÀÌ·ç¾îÁ® °ßÁ¶ÇÏ°Ô ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº º´¿ø ºÎ¹®ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È º´¿ø ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â º´¿ø ȯ°æ¿¡¼­ ¼öÇàµÇ´Â ¼ö¼ú, ¿Ü»ó »ç·Ê, ¸¸¼º »óó Ä¡·á°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ »óó ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. º´¿ø¿¡¼­´Â °¨¿° ´ëÃ¥°ú È¿À²ÀûÀÎ »óó °ü¸®°¡ ¿ì¼±µÇ¾î Á¤È®ÇÑ ¼¼Á¤À» À§ÇÑ °ü°³ ½Ã½ºÅÛÀÇ Ã¤¿ëÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. °ß°íÇÑ ÀÎÇÁ¶ó, ¼÷·ÃµÈ ÀηÂ, ÃÖ÷´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­ÇÏ°í º´¿øÀº ÀÌ·¯ÇÑ È®´ë ÀÇ·á ºÐ¾ßÀÇ ÇÙ½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¸¸¼º »óó, ´ç´¢º´¼º ±Ë¾ç ¹× ¿Ü»ó Áõ°¡·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼±Áø »óó Äɾ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë°¡ ¼ö¿ä¸¦ ´õ¿í ²ø¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °¨¿° ´ëÃ¥À» ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó³ª ¼¼Á¤ ±â±¸ÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ µå·¹½Ì¿¡¼­ ÃÖ½ÅÀÇ È¿À²ÀûÀÎ »óó °ü¸® ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀÌ ÀÌ Áö¿ªÀÇ À¯¸ÁÇÑ Àü¸ÁÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÀÌ Áö¿ªÀÇ °í±Þ ÀÇ·á ÀÎÇÁ¶ó, ¸¸¼º »óó ¹× ¼ö¼ú ÈÄ »óó ¹ß»ý·üÀÇ »ó½Â, °¨¿° ¿¹¹æ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. »óó ÄÉ¾î ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä »ê¾÷ ±â¾÷ÀÇ Á¸Àç¿Í °­·ÂÇÑ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê°¡ ±â¼ú Çõ½Å°ú ä¿ëÀ» ÃËÁøÇÏ°í ºÏ¹Ì¸¦ »óó ¼¼Ã´ ½Ã½ºÅÛÀÇ ¹ßÀü°ú ȯÀÚ °á°ú °³¼±ÀÇ ¸Å¿ì Áß¿äÇÑ ±âÁö·Î ÀÚ¸® ¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¹«·á ÁÖ¹®À» ¹Þ¾Æ¼­ ¸¸µå´Â ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå ÃßÁ¤, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ¼öµ¿
  • ÀüÁö½Ä
  • Á߷½Ä
  • ¾Ð·Â ±â¹Ý

Á¦6Àå ¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå : â»ó À¯Çüº°

  • ¸¸¼º »óó
    • ´ç´¢º´¼º ¹ß±Ë¾ç
    • ¿åâ
    • Á¤¸Æ¼º ´Ù¸® ±Ë¾ç
    • ±âŸ
  • ±Þ¼º »óó
    • ¼ö¼ú »óó
    • ¿Ü»ó
    • È­»ó

Á¦7Àå ¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå : ¿ë¾×º°

  • »ý¸® ½Ä¿°¼ö
  • ¼Òµ¶¾×
  • Ç×»ýÁ¦ ¿ë¾×
  • Ư¼ö ¿ë¾×

Á¦8Àå ¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ »óó ¼¼Ã´ ½Ã½ºÅÛ ½ÃÀå :Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • B. Braun Melsungen AG
  • Smith & Nephew plc
  • Medtronic plc
  • Molnlycke Health Care AB
  • ConvaTec Group PLC
  • BD(Becton, Dickinson and Company)
  • 3M Company
  • Cardinal Health Inc.
  • Coloplast A/S
  • Hollister Incorporated
  • CooperSurgical, Inc.
  • Integra LifeSciences Corporation
  • Schulke & Mayr GmbH
  • Stryker Corporation
  • Centurion Medical Products
  • Zimmer Biomet Holdings, Inc.
  • Aspen Surgical Products, Inc.
  • Irrimax Corporation
  • Medline Industries, LP
SHW 25.08.18

According to Stratistics MRC, the Global Wound Irrigation Systems Market is accounted for $319.9 million in 2025 and is expected to reach $465.3 million by 2032 growing at a CAGR of 5.5% during the forecast period. Wound irrigation systems are medical devices or methods used to cleanse wounds by delivering a controlled flow of solution, typically saline or antiseptic, to remove debris, bacteria, and exudates. These systems help prevent infection, promote faster healing, and maintain a moist wound environment. They are commonly used in surgical wounds, traumatic injuries, chronic ulcers, and burns. Wound irrigation can be performed using manual syringes, gravity-fed systems, or powered irrigation devices. Proper irrigation reduces biofilm formation, enhances tissue regeneration, and prepares the wound bed for dressing or closure.

According to the Health Research Educational Trust (HRET), approximately 15 million surgeries are conducted annually in the U.S., with around 2.0% to 5.0% of patients experiencing surgical site infections.

Market Dynamics:

Driver:

Surging chronic wounds & post surgical care needs

The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure sores, and venous leg ulcers, along with growing post-surgical care needs, is significantly driving the demand for wound irrigation systems. These conditions require consistent and effective wound cleansing to prevent infections and promote healing. As global surgical volumes rise and chronic illnesses become more common, healthcare providers increasingly adopt advanced irrigation systems to ensure sterile wound environments, thus fueling market growth and expanding opportunities for innovation in wound care technologies.

Restraint:

High cost of advanced irrigation systems

The high cost of advanced wound irrigation systems poses a significant barrier to market growth, especially in cost-sensitive and resource-limited regions. These systems, though effective, often require substantial investment in equipment and maintenance, limiting adoption across smaller healthcare facilities and rural settings. This financial burden discourages widespread usage, restricts patient access to advanced care, and slows overall market penetration, particularly in developing economies struggling with budget constraints in healthcare.

Opportunity:

Technological innovation and product evolution

Technological innovation and continuous product evolution are significantly driving the Wound Irrigation Systems Market. Advanced systems featuring automated pressure control, portable designs, and integrated antimicrobial solutions are enhancing precision, safety, and ease of use in wound care. These innovations reduce infection risks, accelerate healing, and improve patient comfort, making them indispensable in both surgical and chronic wound management. As healthcare facilities increasingly adopt smart, efficient irrigation tools, the demand for technologically advanced systems continues to rise, fueling robust market growth.

Threat:

Limited Penetration in Rural and Developing Areas

Limited penetration in rural and developing areas significantly hampers the growth of the wound irrigation systems market. These regions often face inadequate healthcare infrastructure, limited access to advanced medical devices, and a shortage of trained professionals. Consequently, the adoption of wound irrigation systems remains minimal, restricting market expansion. Economic constraints and lack of awareness further aggravate the issue, creating a substantial gap between demand and accessibility in underserved populations.

Covid-19 Impact

The COVID-19 pandemic initially disrupted the Wound Irrigation Systems Market due to postponed elective surgeries and strained hospital capacities. However, as healthcare systems adapted, the demand surged for infection control and wound care solutions in critical care settings. Increased focus on hygiene, prevention of hospital-acquired infections, and post-COVID complications revived growth. The crisis highlighted the importance of efficient wound management, prompting renewed investments and adoption of advanced irrigation technologies.

The acute wounds segment is expected to be the largest during the forecast period

The acute wounds segment is expected to account for the largest market share during the forecast period, due to rising incidence of injuries from accidents, surgeries, and trauma cases. With healthcare providers emphasizing immediate wound cleaning to prevent infections and support faster healing, demand for advanced irrigation systems is surging. Moreover, the increasing adoption of minimally invasive procedures and growing awareness about wound hygiene further boost the market. This segment's clinical urgency ensures steady innovation and robust usage across emergency and surgical settings.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to rising surgical procedures, trauma cases, and chronic wound treatments conducted in hospital settings, the demand for advanced wound care solutions is surging. Hospitals prioritize infection control and efficient wound management, boosting the adoption of irrigation systems for precise cleaning. Their robust infrastructure, skilled personnel, and access to cutting-edge technologies further accelerate market growth, making hospitals a cornerstone of this expanding healthcare segment.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising incidences of chronic wounds, diabetic ulcers, and traumatic injuries. Increasing awareness about advanced wound care, growing elderly population, and expanding healthcare infrastructure are further boosting demand. Additionally, government initiatives promoting infection control, alongside technological advancements in irrigation devices, are accelerating market growth. The shift from traditional dressing to modern, efficient wound management solutions is shaping a promising outlook for the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region's advanced healthcare infrastructure, rising incidence of chronic and post-surgical wounds, and growing awareness of infection prevention. Increased investment in wound care technologies, along with favorable reimbursement policies, is accelerating market growth. Moreover, the presence of key industry players and strong research initiatives are fostering innovation and adoption, positioning North America as a pivotal hub for wound irrigation system advancements and improved patient outcomes.

Key players in the market

Some of the key players profiled in the Wound Irrigation Systems Market include B. Braun Melsungen AG, Smith & Nephew plc, Medtronic plc, Molnlycke Health Care AB, ConvaTec Group PLC, BD (Becton, Dickinson and Company), 3M Company, Cardinal Health Inc., Coloplast A/S, Hollister Incorporated, CooperSurgical, Inc., Integra LifeSciences Corporation, Schulke & Mayr GmbH, Stryker Corporation, Centurion Medical Products, Zimmer Biomet Holdings, Inc., Aspen Surgical Products, Inc., Irrimax Corporation and Medline Industries, LP.

Key Developments:

In February 2025, Philips and Medtronic have signed a landmark Memorandum of Understanding in India to upskill over 300 cardiologists and radiologists in advanced structural heart imaging, focusing on echocardiography and MRI-critical modalities for managing heart disease in patients with End Stage Renal Disease (ESRD).

In November 2024, Yashoda Group of Hospitals entered into a Memorandum of Understanding with Medtronic, naming the company as its Preferred Robotics Partner. This agreement allows Yashoda to deploy Medtronic's Hugo Robotic Assisted Surgery (RAS) platforms across multiple hospitals-building upon a successful installation at their Sanjay Nagar facility

Products Covered:

  • Manual Wound Irrigation Systems
  • Battery-Operated Wound Irrigation Systems
  • Gravity Feed Systems
  • Pressure-Based Systems

Wound Types Covered:

  • Chronic wounds
  • Acute wounds

Solutions Covered:

  • Normal Saline
  • Antiseptic Solutions
  • Antibiotic Solutions
  • Specialized Solutions

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Wound Irrigation Systems Market, By Product

  • 5.1 Introduction
  • 5.2 Manual Wound Irrigation Systems
  • 5.3 Battery-Operated Wound Irrigation Systems
  • 5.4 Gravity Feed Systems
  • 5.5 Pressure-Based Systems

6 Global Wound Irrigation Systems Market, By Wound Type

  • 6.1 Introduction
  • 6.2 Chronic wounds
    • 6.2.1 Diabetic foot ulcer
    • 6.2.2 Pressure ulcer
    • 6.2.3 Venous leg ulcer
    • 6.2.4 Other chronic wounds
  • 6.3 Acute wounds
    • 6.3.1 Surgical wounds
    • 6.3.2 Traumatic wounds
    • 6.3.3 Burns

7 Global Wound Irrigation Systems Market, By Solution

  • 7.1 Introduction
  • 7.2 Normal Saline
  • 7.3 Antiseptic Solutions
  • 7.4 Antibiotic Solutions
  • 7.5 Specialized Solutions

8 Global Wound Irrigation Systems Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Clinics
  • 8.5 Homecare Settings
  • 8.6 Other End Users

9 Global Wound Irrigation Systems Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 B. Braun Melsungen AG
  • 11.2 Smith & Nephew plc
  • 11.3 Medtronic plc
  • 11.4 Molnlycke Health Care AB
  • 11.5 ConvaTec Group PLC
  • 11.6 BD (Becton, Dickinson and Company)
  • 11.7 3M Company
  • 11.8 Cardinal Health Inc.
  • 11.9 Coloplast A/S
  • 11.10 Hollister Incorporated
  • 11.11 CooperSurgical, Inc.
  • 11.12 Integra LifeSciences Corporation
  • 11.13 Schulke & Mayr GmbH
  • 11.14 Stryker Corporation
  • 11.15 Centurion Medical Products
  • 11.16 Zimmer Biomet Holdings, Inc.
  • 11.17 Aspen Surgical Products, Inc.
  • 11.18 Irrimax Corporation
  • 11.19 Medline Industries, LP
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦